| [1] |
Sauer R, Becker H, Hohenberger W, et al. Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med, 2004, 351(17): 1731-1740.
|
| [2] |
Bosset JF, Collette L, Calais G, et al. Chemotherapy with preoperative radiotherapy in rectal cancer. N Engl J Med, 2006, 355(11):1114-1123.
|
| [3] |
Swedish Rectal Cancer Trial. Improved survival with preoperative radiotherapy in rectal cancer. N Engl J Med, 1997, 336(14): 980-987.
|
| [4] |
Smith JJ, Garcia-Aguilar J. Advances and challenges in treatment of locally advanced rectal cancer. J Clin Oncol, 2015, 133(16): 1797-1808.
|
| [5] |
Samdani T, Garcia-Aguilar J. Imaging in rectal cancer: magnetic resonance imaging vs. endorectal ultrasonography. Surg Oncol Clin N Am, 2014, 23(1): 59-77.
|
| [6] |
Brown G, Davies S, Williams GT,et al. Effectiveness of preoperative staging in rectal cancer: digital rectal examination, endoluminal ultrasound or magnetic resonance imaging? Br J Cancer, 2004, 91(1):23-29.
|
| [7] |
Al-Sukhni E, Milot L, Fruitman M, et al. Diagnostic accuracy of MRI for assessment of T category, lymph node metastases, and circumferential resection margin involvement in patients with rectal cancer: a systematic review and meta analysis. Ann Surg Oncol, 2012, 19(7): 2212-2223.
|
| [8] |
Merkel S, Mansmann U, Siassi M, et al. The prognostic inhomogeneity in pT3 rectal carcinomas. Int J Colorectal Dis, 2001, 16(5): 298-304.
|
| [9] |
Shin R, Jeong SY, Yoo HY, et al. Depth of mesorectal extension has prognostic significance in patients with T3 rectal cancer. Dis Colon Rectum, 2012, 55(12): 1220-1228.
|
| [10] |
MERCURY Study Group. Extramural depth of tumor invasion at thin-section MR in patients with rectal cancer: results of the MERCURY study. Radiology, 2007, 243(1): 132-139.
|
| [11] |
Glimelius B, Tiret E, Cervantes A, et al. Rectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol, 2013, 24 (Suppl6): vi81-88.
|
| [12] |
Redel C, Sauer R. Neoedjuvant radiochemotherapy in rectal cancer；For which patient and tumor stages? Front Radiat Ther Oncol, 2004, 38(1): 13-23.
|
| [13] |
Bujko K, Nowacki MP, Nasierowska-Guttmejer A, et al. Long-term results of a randomized trial comparing preoperative short-course radiotherapy with preoperative conventionally fractionated chemoradiation for rectal cancer. Br J Surg, 2006, 93(10): 1215-1223.
|
| [14] |
Maas M, Nelemans PJ, Valentini V, et al. Long-term outcome in patients with a pathological complete response after chemoradiation for rectal cancer: a pooled analysis of individual patient data. Lancet Oncol, 2010, 11(9): 835-844.
|
| [15] |
Park IJ, You YN, Agarwal A, et al. Neoadjuvant treatment response as an early response indicator for patients with rectal cancer. J Clin Oncol, 2012; 30(15): 1770-1776.
|
| [16] |
Washington MK, Berlin J, Branton P, et al. Protocol for the examination of specimens from patients with primary carcinoma of the colon and retum. Arch Pathol Lab Med, 2009, 133(10):1539-1551.
|
| [17] |
Mandard AM, Dalibard F, Mandard JC, et al. Pathologic assessment of tumor regression after preoperative chemoradiotherapy of esophageal carcinoma. Clinicopathologic correlations. Cancer, 1994, 73(11): 2680-2686.
|
| [18] |
Dworak O, Keilholz L, Hoffmann A. Pathological features of rectal cancer after preoperative radiochemotherapy. Int J Colorectal Dis, 1997, 12(1): 19-23.
|
| [19] |
Ryan R, Gibbons D, Hyland JM, et al. Pathological response following long-course neoadjuvant chemoradiotherapy for locally advance rectal cancer. Histopathology, 2005, 47(2): 141-146.
|
| [20] |
Smith KD, Tan D, Das P, et al. Clinical significance of acelluar mucin in rectal adenocarcinoma patients with a pathologic complete response to preoperative chemoradiation. Ann Surg, 2010, 251(2): 261-264.
|
| [21] |
Lim SB, Hong SM, Yu CS, et al. Prevalence and clinical significande of acelluar mucin in locally rectal cancer patients showing pathologic complete response to preoperative chemoradiotherapy. Am J Surg Pathol, 2013, 37(1): 47-52.
|
| [22] |
Shihab OC, Taylor F, Salerno G, et al. MRI predictive factors for long-term outcomes of low rectal tumours. Ann Surg Oncol, 2011, 18(12): 3278-3284.
|
| [23] |
Lambregts DM, Vandercaveye V, Barbaro B, et al. Diffusion-Weighted MRI for selection of complete responders after chemoradiation for locally advanced rectal cancer: a multicenter study. Ann Surg Oncol, 2011, 18(8): 2224-2231.
|
| [24] |
Hein PA, Kremser C, Judmaier W, et al. Diffusion-Weighted magnetic resonance imaging for monitoring diffusion changes in rectal carcinoma during combined, preoperative chemoradiation: preliminary results of a prospective study. Eur J Radiol, 2003, 45(2): 214-222.
|